Cargando…
Mitochondrial DNA methylation is a predictor of immunotherapy response and prognosis in breast cancer: scRNA-seq and bulk-seq data insights
BACKGROUND: Alterations in Mitochondrial DNA methylation (MTDM) exist in many tumors, but their role in breast cancer (BC) development remains unclear. METHODS: We analyzed BC patient data by combining scRNA-seq and bulk sequencing. Weighted co-expression network analysis (WGCNA) of TCGA data identi...
Autores principales: | Ma, Yixuan, Du, Juan, Chen, Meini, Gao, Ning, Wang, Sijia, Mi, Zhikuan, Wei, Xiaoli, Zhao, Jumei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339346/ https://www.ncbi.nlm.nih.gov/pubmed/37457713 http://dx.doi.org/10.3389/fimmu.2023.1219652 |
Ejemplares similares
-
Exploring PANoptosis in breast cancer based on scRNA-seq and bulk-seq
por: He, Puxing, et al.
Publicado: (2023) -
Evaluating the role of IDO1 macrophages in immunotherapy using scRNA-seq and bulk-seq in colorectal cancer
por: Liu, Xingwu, et al.
Publicado: (2022) -
Mast cell marker gene signature: prognosis and immunotherapy response prediction in lung adenocarcinoma through integrated scRNA-seq and bulk RNA-seq
por: Zhang, Pengpeng, et al.
Publicado: (2023) -
ScRNA-seq and ST-seq in liver research
por: He, Jia, et al.
Publicado: (2023) -
ScRNA-seq and bulk RNA-seq reveal the characteristics of ferroptosis and establish a risk signature in cholangiocarcinoma
por: Yao, Wenchao, et al.
Publicado: (2022)